This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study to Compare Effectiveness and Safety of ABP 5...
Clinical trial

Study to Compare Effectiveness and Safety of ABP 501 and Adalimumab (Humira ®) in Adults With Moderate to Severe Plaque Psoriasis

Read time: 1 mins
Last updated:23rd Oct 2013

The purpose of this research study is to compare the effectiveness and safety of ABP 501 and Adalimumab (Humira) in adult subjects with plaque psoriasis.

Category Value
Study start date 2013-10-23

View full details